Julian Wann

Global Category Leader Freight & Logistics
AstraZeneca


9:00 AM CASE STUDY: Why AstraZeneca are on Course to Achieve 70% Sea Volume Ratio by 2018

• Discover how utilising sea freight can better ensure that: product quality is maintained, temperature excursions are reduced, transportation is more sustainable, and supply chain cost are lower
• Examine the strategies that that AstraZeneca have employed in their significant modal shift
• Benchmark your own sea freight strategy with other pharma manufactures